Cargando…
Platelets activated by the anti-β2GPI/β2GPI complex release microRNAs to inhibit migration and tube formation of human umbilical vein endothelial cells
BACKGROUND: Patients with anti-β2GPI antibodies display significantly higher platelet activation/aggregation and vascular endothelial cell damage. The mechanism underlying the correlation between platelet activation, vascular endothelial cell dysfunctions and anti-β2GPI antibodies remains unknown. M...
Autores principales: | Zhang, Yanfen, Zhang, Wenjing, Zha, Caijun, Liu, Yanhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952642/ https://www.ncbi.nlm.nih.gov/pubmed/29785186 http://dx.doi.org/10.1186/s11658-018-0091-3 |
Ejemplares similares
-
Anti‐β2GPI/β2GPI induces human neutrophils to generate NETs by relying on ROS
por: You, Yanqiu, et al.
Publicado: (2019) -
Anti-β(2)GPI/β(2)GPI induces neutrophil pyroptosis and thereby enhances ICAM-1 and IL-8 expression in endothelial cells
por: Luo, Jie, et al.
Publicado: (2022) -
Effects of anti‐β2GPI antibodies on VWF release from human umbilical vein endothelial cells and ADAMTS13 activity
por: Ng, Christopher J., et al.
Publicado: (2018) -
PredGPI: a GPI-anchor predictor
por: Pierleoni, Andrea, et al.
Publicado: (2008) -
Pro-atherogenic activation of A7r5 cells induced by the oxLDL/β(2)GPI/anti-β(2)GPI complex
por: Wang, Ting, et al.
Publicado: (2018)